The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors

Nature Immunology

Volumn 11, Issue 5, 2010, Pages 373-384

  Kawai, Taro ^a,b   Akira, Shizuo ^a,b  

^a World Premier International Immunology Frontier Research Center   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CPG OLIGODEOXYNUCLEOTIDE; DOUBLE STRANDED RNA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MEMBRANE PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID; PROTEIN MD 2; PROTEIN PRAT4; PROTEIN UNC93B1; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRISTERAPROLIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; HOST RESISTANCE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFECTION SENSITIVITY; INNATE IMMUNITY; MISSENSE MUTATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; RNA VIRUS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION; VIRUS REPLICATION;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; NUCLEIC ACIDS; NUCLEOPROTEINS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 77951260924     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1863     Document Type: Review

References (136)

1. Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680 (2001). (Pubitemid 32747155)
2. Janeway, C.A. Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197-216 (2002). (Pubitemid 34293424)
3. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006). (Pubitemid 43261452)
4. Jin, M.S. & Lee, J.O. Structures of the Toll-like receptor family and its ligand complexes. Immunity 29, 182-191 (2008).
5. Kawai, T. & Akira, S. Innate immune recognition of viral infection. Nat. Immunol. 7, 131-137 (2006). (Pubitemid 43135878)
6. Barbalat, R., Lau, L., Locksley, R.M. & Barton, G.M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 10, 1200-1207 (2009).
7. Yoneyama, M. & Fujita, T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 227, 54-65 (2009).
8. Franchi, L., eigenbrod, T., Munoz-Planillo, R. & Nunez, G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease patho-genesis. Nat. Immunol. 10, 241-247 (2009).
9. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
10. Ishii, K.J. et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7, 40-48 (2006).
11. Stetson, D.B. & Medzhitov, R. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24, 93-103 (2006). (Pubitemid 43077203)
12. Akashi-Takamura, S. & Miyake, K. TLR accessory molecules. Curr. Opin. Immunol. 20, 420-425 (2008).
13. Kim, H.M. et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran. Cell 130, 906-917 (2007).
14. Park, B.S. et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191-1195 (2009).
15. Jin, M.S. et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130, 1071-1082 (2007).
16. Kang, J.Y. et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31, 873-884 (2009).
17. Hoebe, K. et al. CD36 is a sensor of diacylglycerides. Nature 433, 523-527 (2005). (Pubitemid 40204309)
18. Goodridge, H.S. & Underhill, D.M. Fungal recognition by TLR2 and dectin-1. Handb. Exp. Pharmacol. 183, 87-109 (2008).
19. Uematsu, S. et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9, 769-776 (2008). (Pubitemid 351859160)
20. Zhang, D. et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303, 1522-1526 (2004). (Pubitemid 38314423)
21. Yarovinsky, F. et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308, 1626-1629 (2005). (Pubitemid 40807512)
22. Choe, J., Kelker, M.S. & wilson, I.A. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309, 581-585 (2005).
23. Bell, J.K., Askins, J., Hall, P.R., Davies, D.R. & Segal, D.M. The dsRNA binding site of human Toll-like receptor 3. Proc. Natl. Acad. Sci. USA 103, 8792-8797 (2006). (Pubitemid 43878098)
24. Kawai, T. & Akira, S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci. 1143, 1-20 (2008).
25. Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101, 3516-3521 (2004). (Pubitemid 38338227)
26. Zhang, S.Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522-1527 (2007) (Pubitemid 47417427)
27. Hornung, v. et al. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263-270 (2005).
28. Mancuso, G. et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10, 587-594 (2009).
29. Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N. & Iwasaki, A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 315, 1398-1401 (2007). (Pubitemid 46399546)
30. Haas, T. et al. The DNA sugar backbone 2′ deoxyribose determines Toll-like receptor 9 activation. Immunity 28, 315-323 (2008). (Pubitemid 351335308)
31. Coban, C. et al. Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9. Cell Host Microbe 7, 50-61 (2010).
32. Kim, Y.M., Brinkmann, M.M., Paquet, M.e. & Ploegh, H.L. UNC93B1 delivers nucle-otide-sensing toll-like receptors to endolysosomes. Nature 452, 234-238 (2008).
33. Tabeta, K. et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7, 156-164 (2006). (Pubitemid 43135881)
34. Casrouge, A. et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314, 308-312 (2006). (Pubitemid 44571977)
35. Brinkmann, M.M. et al. The interaction between the eR membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J. Cell Biol. 177, 265-275 (2007). (Pubitemid 46658638)
36. Kiyokawa, T. et al. A single base mutation in the PRAT4A gene reveals differential interaction of PRAT4A with Toll-like receptors. Int. Immunol. 20, 1407-1415 (2008).
37. Takahashi, K. et al. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J. Exp. Med. 204, 2963-2976 (2007). (Pubitemid 350179564)
38. Yang, Y. et al. Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 26, 215-226 (2007). (Pubitemid 46329432)
39. Ewald, S.E. et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658-662 (2008).
40. Park, B. et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 9, 1407-1414 (2008).
41. Asagiri, M. et al. Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis. Science 319, 624-627 (2008). (Pubitemid 351197065)
42. Matsumoto, F. et al. Cathepsins are required for Toll-like receptor 9 responses. Biochem. Biophys. Res. Commun. 367, 693-699 (2008).
43. Sepulveda, F.E. et al. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31, 737-748 (2009)
44. Peter, M.e., Kubarenko, A.v., weber, A.N. & Dalpke, A.H. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. J. Immunol. 182, 7690-7697 (2009).
45. Kagan, J.C. & Medzhitov, R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943-955 (2006). (Pubitemid 43795199)
46. Rowe, D.C. et al. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. Acad. Sci. USA 103, 6299-6304 (2006).
47. Kagan, J.C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-p. Nat. Immunol. 9, 361-368 (2008).
48. Tanimura, N., Saitoh, S., Matsumoto, F., Akashi-Takamura, S. & Miyake, K. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem. Biophys. Res. Commun. 368, 94-99 (2008).
49. Kawagoe, T. et al. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9, 684-691 (2008). (Pubitemid 351712639)
50. Bhoj, V.G. & Chen, Z.J. Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437 (2009).
51. Yamamoto, M. et al. Key function for the Ubc13 e2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7, 962-970 (2006). (Pubitemid 44263910)
52. Tokunaga, F. et al. Involvement of linear polyubiquitylation of NeMO in NF-KB activation. Nat. Cell Biol. 11, 123-132 (2009).
53. Rahighi, S. et al. Specific recognition of linear ubiquitin chains by NeMO is important for NF-KB activation. Cell 136, 1098-1109 (2009).
54. Lo, Y.C. et al. Structural basis for recognition of diubiquitins by NeMO. Mol. Cell 33, 602-615 (2009).
55. Yamamoto, M. et al. Regulation of Toll/I L-1-receptor-mediated gene expression by the inducible nuclear protein IKB£,. Nature 430, 218-222 (2004). (Pubitemid 38902431)
56. Litvak, V. et al. Function of C/eBPS in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat. Immunol. 10, 437-443 (2009).
57. Kuwata, H. et al. IKBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. Immunity 24, 41-51 (2006). (Pubitemid 43077199)
58. Gilchrist, M. et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441, 173-178 (2006).
59. Pobezinskaya, YL. et al. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors. Nat. Immunol. 9, 1047-1054 (2008).
60. ermolaeva, M.A. et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat. Immunol. 9, 1037-1046 (2008).
61. Chang, M., Jin, w. & Sun, S.C. Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat. Immunol. 10, 1089-1095 (2009).
62. Hacker, H. & Karin, M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 357, re13 (2006).
63. Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006). (Pubitemid 43083141)
64. Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature 439, 208-211 (2006). (Pubitemid 43083142)
65. Tseng, P.H. et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11, 70-75 (2010)
66. wang, C. et al. The e3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat. Immunol. 10, 744-752 (2009).
67. Shinohara, M.L. et al. Osteopontin expression is essential for interferon-a production by plasmacytoid dendritic cells. Nat. Immunol. 7, 498-506 (2006).
68. Cao, W. et al. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway. Nat. Immunol. 9, 1157-1164 (2008).
69. Takaoka, A. et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434, 243-249 (2005). (Pubitemid 40388058)
70. Tsujimura, H. et al. Toll-like receptor 9 signaling activates NF-κB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 172, 6820-6827 (2004). (Pubitemid 38669120)
71. Honda, K. et al. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035-1040 (2005). (Pubitemid 40586053)
72. Palsson-McDermott, E.M. et al. TAG, a splice variant of the adaptor TRAM, negatively regulates the adaptor MyD88-independent TLR4 pathway. Nat. Immunol. 10, 579-586 (2009).
73. Carty, M. et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat. Immunol. 7, 1074-1081 (2006). (Pubitemid 44420652)
74. Shi, M. et al. TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 9, 369-377 (2008). (Pubitemid 351405106)
75. Tanaka, T., Grusby, M.J. & Kaisho, T. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 8, 584-591 (2007). (Pubitemid 46785122)
76. Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628-1632 (2007). (Pubitemid 350233662)
77. Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486 (2006). (Pubitemid 44267285)
78. Sheedy, F.J. et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11, 141-147 (2010).
79. Kawagoe, T. et al. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat. Immunol. 10, 965-972 (2009).
80. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007). (Pubitemid 46184351)
81. Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264-268 (2008).
82. Cadwell, K. et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456, 259-263 (2008).
83. Matsushita, K. et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458, 1185-1190 (2009).
84. Carrick, D.M., Lai, w.S. & Blackshear, P.J. The tandem CCCH zinc finger protein tristetraprolin and its relevance to cytokine mRNA turnover and arthritis. Arthritis Res. Ther. 6, 248-264 (2004).
85. Turer, E.E. et al. Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20. J. Exp. Med. 205, 451-464 (2008).
86. Croker, B.A. et al. Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc. Natl. Acad. Sci. USA 105, 15028-15033 (2008).
87. An, H. et al. Phosphatase SHP-1 promotes TLR-and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9, 542-550 (2008). (Pubitemid 351560523)
88. Ishikawa, H., Ma, Z. & Barber, G.N. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792 (2009).
89. Takaoka, A. et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501-505 (2007). (Pubitemid 47123520)
90. Ishii, K.J. et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451, 725-729 (2008).
91. Hornung, V. & Latz, e. Intracellular DNA recognition. Nat. Rev. Immunol. 10, 123-130 (2010).
92. Fernandes-Alnemri, T. et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat. Immunol. advance online publication, doi:10.1038/ni1859 (28 March 2010).
93. Rathinam, V.A. et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat. Immunol. advance online publication, doi:10.1038/ni.1864 (29 March 2010).
94. Okabe, Y., Sano, T. & Nagata, S. Regulation of the innate immune response by threo-nine-phosphatase of eyes absent. Nature 460, 520-524 (2009).
95. Koyama, S. et al. Differential role of TLR-and RLR-signaling in the immune responses to influenza A virus infection and vaccination. J. Immunol. 179, 4711-4720 (2007).
96. Jung, A. et al. Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88. J. Virol. 82, 196-206 (2008). (Pubitemid 350309136)
97. Allen, I.C. et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30, 556-565 (2009).
98. Thomas, P.G. et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30, 566-575 (2009).
99. Ichinohe, T., Lee, H.K., Ogura, Y., Flavell, R. & Iwasaki, A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206, 79-87 (2009).
100. Ichinose, T., Pang, I.K. & Iwasaki, A. Influenza virus activates inflammasomes through intracellular M2 channel. Nat. Immunol. advance online publication, doi:10.1038/ni.1861 (11 April 2010).
101. Schulz, O. et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433, 887-892 (2005). (Pubitemid 40314900)
102. Kumar, H., Koyama, S., Ishii, K.J., Kawai, T. & Akira, S. Cooperation of IPS-1-and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J. Immunol. 180, 683-687 (2008).
103. + Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206, 1589-1602 (2009).
104. Schaefer, L. et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115, 2223-2233 (2005). (Pubitemid 41134165)
105. Jiang, D. et al. Regulation of lung injury and repair by Toll-like receptors and hyaluro-nan. Nat. Med. 11, 1173-1179 (2005). (Pubitemid 43093664)
106. Kim, S. et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102-106 (2009).
107. Okamura, Y. et al. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233 (2001). (Pubitemid 37391934)
108. Guillot, L. et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168, 5989-5992 (2002). (Pubitemid 34620010)
109. Yang, H. & Tracey, K.J. Targeting HMGB1 in inflammation. Biochim. Biophys. Acta 1799, 149-156 (2009).
110. Tsung, A. et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201, 1135-1143 (2005). (Pubitemid 40524681)
111. Yanai, H. et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462, 99-103 (2009).
112. Tsan, M.F. & Gao, B. Heat shock proteins and immune system. J. Leukoc. Biol. 85, 905-910 (2009).
113. Stewart, C.R. et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-161 (2010).
114. Biragyn, A. et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298, 1025-1029 (2002). (Pubitemid 35247310)
115. Imai, Y. et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133, 235-249 (2008). (Pubitemid 351512299)
116. Barton, G.M., Kagan, J.C. & Medzhitov, R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7, 49-56 (2006). (Pubitemid 41823868)
117. Marshak-Rothstein, A. & Rifkin, I.R. Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25, 419-441 (2007). (Pubitemid 46697913)
118. Means, T.K. et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407-417 (2005).
119. vollmer, J. et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202, 1575-1585 (2005). (Pubitemid 41746603)
120. viglianti, G.A. et al. Activation of autoreactive B cells by CpG dsDNA. Immunity 19, 837-847 (2003).
121. Tian, J. et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGe. Nat. Immunol. 8, 487-496 (2007). (Pubitemid 46605917)
122. Lande, R. et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449, 564-569 (2007). (Pubitemid 47525141)
123. Ganguly, D. et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983-1994 (2009).
124. Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669-1672 (2006). (Pubitemid 43902669)
125. Fairhurst, A.M. et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 38, 1971-1978 (2008).
126. Lee, P.Y. et al. TLR7-dependent and FcγR-independent production of type I inter-feron in experimental mouse lupus. J. Exp. Med. 205, 2995-3006 (2008).
127. Christensen, S.R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417-428 (2006).
128. Napirei, M. et al. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25, 177-181 (2000). (Pubitemid 30394988)
129. Yasutomo, K. et al. Mutation of DNASe1 in people with systemic lupus erythema-tosus. Nat. Genet. 28, 313-314 (2001). (Pubitemid 32702418)
130. Kawane, K. et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443, 998-1002 (2006). (Pubitemid 44646177)
131. Crow, Y.J. et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TReX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat. Genet. 38, 917-920 (2006).
132. Lee-Kirsch, M.A. et al. Mutations in the gene encoding the 3′-5′ DNA exonu-clease TReX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065-1067 (2007).
133. Stetson, D.B., Ko, J.S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598 (2008).
134. Zheng, L. et al. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nat. Med. 13, 812-819 (2007). (Pubitemid 47038189)
135. Rice, G.I. et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41, 829-832 (2009).
136. Amit, I. et al. Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326, 257-263 (2009).